Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.96838039 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.91553528 |
3 | L-phenylalanine metabolic process (GO:0006558) | 4.91553528 |
4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.83575160 |
5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.83575160 |
6 | L-phenylalanine catabolic process (GO:0006559) | 4.70343617 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.70343617 |
8 | NADH metabolic process (GO:0006734) | 4.65341980 |
9 | alpha-linolenic acid metabolic process (GO:0036109) | 4.52237518 |
10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.51158259 |
11 | proline biosynthetic process (GO:0006561) | 4.49389520 |
12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.17783012 |
13 | 2-oxoglutarate metabolic process (GO:0006103) | 4.16479658 |
14 | protein retention in ER lumen (GO:0006621) | 4.13077825 |
15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.09324900 |
16 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.04390155 |
17 | protein maturation by protein folding (GO:0022417) | 4.03103879 |
18 | lysine metabolic process (GO:0006553) | 3.93793455 |
19 | lysine catabolic process (GO:0006554) | 3.93793455 |
20 | pentose-phosphate shunt (GO:0006098) | 3.85914388 |
21 | valine metabolic process (GO:0006573) | 3.85274286 |
22 | kynurenine metabolic process (GO:0070189) | 3.84034788 |
23 | 4-hydroxyproline metabolic process (GO:0019471) | 3.79009107 |
24 | sulfur amino acid catabolic process (GO:0000098) | 3.78596739 |
25 | protein carboxylation (GO:0018214) | 3.78583350 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.78583350 |
27 | aromatic amino acid family catabolic process (GO:0009074) | 3.78060970 |
28 | barbed-end actin filament capping (GO:0051016) | 3.77086389 |
29 | glyoxylate metabolic process (GO:0046487) | 3.73112707 |
30 | regulation of cholesterol homeostasis (GO:2000188) | 3.72941402 |
31 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.63752986 |
32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.61913450 |
33 | negative regulation of fibrinolysis (GO:0051918) | 3.60383946 |
34 | urea cycle (GO:0000050) | 3.60117091 |
35 | urea metabolic process (GO:0019627) | 3.60117091 |
36 | protein localization to endosome (GO:0036010) | 3.58098097 |
37 | pinocytosis (GO:0006907) | 3.56328930 |
38 | plasma lipoprotein particle clearance (GO:0034381) | 3.55779383 |
39 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.52434299 |
40 | regulation of triglyceride catabolic process (GO:0010896) | 3.52190669 |
41 | tricarboxylic acid metabolic process (GO:0072350) | 3.51722536 |
42 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.51408024 |
43 | cysteine metabolic process (GO:0006534) | 3.49880585 |
44 | bile acid biosynthetic process (GO:0006699) | 3.49314667 |
45 | nucleotide salvage (GO:0043173) | 3.47410514 |
46 | oxaloacetate metabolic process (GO:0006107) | 3.46263438 |
47 | fatty acid beta-oxidation (GO:0006635) | 3.44862011 |
48 | NADPH regeneration (GO:0006740) | 3.41102978 |
49 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.39926782 |
50 | nitrogen cycle metabolic process (GO:0071941) | 3.37998438 |
51 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.35847878 |
52 | glucose catabolic process (GO:0006007) | 3.32210266 |
53 | complement activation, alternative pathway (GO:0006957) | 3.31918587 |
54 | negative regulation of sterol transport (GO:0032372) | 3.29127646 |
55 | negative regulation of cholesterol transport (GO:0032375) | 3.29127646 |
56 | short-chain fatty acid metabolic process (GO:0046459) | 3.28812500 |
57 | aspartate family amino acid catabolic process (GO:0009068) | 3.24382735 |
58 | fatty acid catabolic process (GO:0009062) | 3.24273586 |
59 | UV protection (GO:0009650) | 3.23253585 |
60 | cellular ketone body metabolic process (GO:0046950) | 3.23209396 |
61 | regulation of fatty acid oxidation (GO:0046320) | 3.22801313 |
62 | purine nucleotide salvage (GO:0032261) | 3.21982407 |
63 | fatty acid oxidation (GO:0019395) | 3.21862054 |
64 | phospholipid efflux (GO:0033700) | 3.21567438 |
65 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.21125897 |
66 | amino-acid betaine metabolic process (GO:0006577) | 3.20366070 |
67 | monosaccharide biosynthetic process (GO:0046364) | 3.19986707 |
68 | regulation of fibrinolysis (GO:0051917) | 3.17112340 |
69 | cellular modified amino acid catabolic process (GO:0042219) | 3.16589279 |
70 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.15032559 |
71 | gluconeogenesis (GO:0006094) | 3.14646294 |
72 | reverse cholesterol transport (GO:0043691) | 3.14229500 |
73 | lipid oxidation (GO:0034440) | 3.13628176 |
74 | mitochondrial fusion (GO:0008053) | 3.10969211 |
75 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.10249262 |
76 | regulation of protein activation cascade (GO:2000257) | 3.10215113 |
77 | monocarboxylic acid catabolic process (GO:0072329) | 3.09878636 |
78 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.09589557 |
79 | Golgi transport vesicle coating (GO:0048200) | 3.09190269 |
80 | COPI coating of Golgi vesicle (GO:0048205) | 3.09190269 |
81 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.07866786 |
82 | tryptophan catabolic process (GO:0006569) | 3.06475182 |
83 | indole-containing compound catabolic process (GO:0042436) | 3.06475182 |
84 | indolalkylamine catabolic process (GO:0046218) | 3.06475182 |
85 | positive regulation of lipid catabolic process (GO:0050996) | 3.06012090 |
86 | plasma lipoprotein particle remodeling (GO:0034369) | 3.04481207 |
87 | protein-lipid complex remodeling (GO:0034368) | 3.04481207 |
88 | macromolecular complex remodeling (GO:0034367) | 3.04481207 |
89 | regulation of cholesterol esterification (GO:0010872) | 3.04403821 |
90 | low-density lipoprotein particle clearance (GO:0034383) | 3.04042198 |
91 | negative regulation of cell size (GO:0045792) | 3.03884967 |
92 | triglyceride homeostasis (GO:0070328) | 3.03087105 |
93 | acylglycerol homeostasis (GO:0055090) | 3.03087105 |
94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.01792363 |
95 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.99398953 |
96 | positive regulation of histone deacetylation (GO:0031065) | 2.99361591 |
97 | homocysteine metabolic process (GO:0050667) | 2.98664220 |
98 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.98660848 |
99 | creatine metabolic process (GO:0006600) | 2.98499629 |
100 | acetyl-CoA metabolic process (GO:0006084) | 2.96875742 |
101 | nuclear envelope reassembly (GO:0031468) | 2.96843754 |
102 | mitotic nuclear envelope reassembly (GO:0007084) | 2.96843754 |
103 | hexose biosynthetic process (GO:0019319) | 2.95989464 |
104 | proline metabolic process (GO:0006560) | 2.95944918 |
105 | positive regulation of fatty acid oxidation (GO:0046321) | 2.95889662 |
106 | plasma lipoprotein particle assembly (GO:0034377) | 2.95722500 |
107 | ethanol oxidation (GO:0006069) | 2.95575452 |
108 | actin-myosin filament sliding (GO:0033275) | 2.94213480 |
109 | muscle filament sliding (GO:0030049) | 2.94213480 |
110 | bile acid metabolic process (GO:0008206) | 2.91089224 |
111 | glutamate metabolic process (GO:0006536) | 2.90727176 |
112 | regulation of complement activation (GO:0030449) | 2.90177981 |
113 | protein-lipid complex assembly (GO:0065005) | 2.89088975 |
114 | histone arginine methylation (GO:0034969) | 2.88967124 |
115 | coenzyme catabolic process (GO:0009109) | 2.88848566 |
116 | maternal placenta development (GO:0001893) | 2.87732911 |
117 | tryptophan metabolic process (GO:0006568) | 2.87434447 |
118 | serine family amino acid catabolic process (GO:0009071) | 2.86082225 |
119 | regulation of cholesterol metabolic process (GO:0090181) | 2.85399442 |
120 | alpha-amino acid catabolic process (GO:1901606) | 2.85203565 |
121 | fatty acid transmembrane transport (GO:1902001) | 2.84371733 |
122 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.84156072 |
123 | tricarboxylic acid cycle (GO:0006099) | 2.83000349 |
124 | regulation of cholesterol storage (GO:0010885) | 2.82803614 |
125 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.82783952 |
126 | regulation of triglyceride metabolic process (GO:0090207) | 2.81461059 |
127 | glycosphingolipid catabolic process (GO:0046479) | 2.80824647 |
128 | glycolytic process (GO:0006096) | 2.80334264 |
129 | glycine metabolic process (GO:0006544) | 2.79800636 |
130 | phospholipid homeostasis (GO:0055091) | 2.79230997 |
131 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.78884603 |
132 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.78426709 |
133 | carnitine metabolic process (GO:0009437) | 2.76843754 |
134 | neutral lipid catabolic process (GO:0046461) | 2.76556457 |
135 | acylglycerol catabolic process (GO:0046464) | 2.76556457 |
136 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.76474971 |
137 | regulation of lipid catabolic process (GO:0050994) | 2.75450414 |
138 | DNA unwinding involved in DNA replication (GO:0006268) | 2.75053112 |
139 | cellular amino acid catabolic process (GO:0009063) | 2.74909008 |
140 | positive regulation of nuclease activity (GO:0032075) | 2.72382130 |
141 | cellular protein complex localization (GO:0034629) | 2.68967305 |
142 | response to thyroid hormone (GO:0097066) | 2.66141031 |
143 | GDP-mannose metabolic process (GO:0019673) | 2.62483411 |
144 | glycolipid catabolic process (GO:0019377) | 2.61382376 |
145 | cellular hyperosmotic response (GO:0071474) | 2.60617648 |
146 | modulation by symbiont of host cellular process (GO:0044068) | 2.60551948 |
147 | skeletal muscle contraction (GO:0003009) | 2.58349078 |
148 | NIK/NF-kappaB signaling (GO:0038061) | 2.57212651 |
149 | negative regulation of necroptotic process (GO:0060546) | 2.56903651 |
150 | regulation of superoxide anion generation (GO:0032928) | 2.56559190 |
151 | pyrimidine nucleoside salvage (GO:0043097) | 2.56339233 |
152 | pyrimidine-containing compound salvage (GO:0008655) | 2.56339233 |
153 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.55550017 |
154 | protein complex localization (GO:0031503) | 2.55008406 |
155 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.54933890 |
156 | pentose metabolic process (GO:0019321) | 2.54678810 |
157 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.54664459 |
158 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.52510306 |
159 | IMP metabolic process (GO:0046040) | 2.50242727 |
160 | peptidyl-arginine N-methylation (GO:0035246) | 2.49994382 |
161 | peptidyl-arginine methylation (GO:0018216) | 2.49994382 |
162 | apoptotic process involved in morphogenesis (GO:0060561) | 2.49306167 |
163 | ER-nucleus signaling pathway (GO:0006984) | 2.46502773 |
164 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.45957163 |
165 | galactose catabolic process (GO:0019388) | 2.42265608 |
166 | regulation of necrotic cell death (GO:0010939) | 2.42025529 |
167 | regulation of nuclease activity (GO:0032069) | 2.40996525 |
168 | activation of MAPKKK activity (GO:0000185) | 2.40723342 |
169 | regulation of early endosome to late endosome transport (GO:2000641) | 2.40705679 |
170 | modulation by virus of host morphology or physiology (GO:0019048) | 2.39887370 |
171 | regulation of mitochondrial membrane potential (GO:0051881) | 2.39212604 |
172 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.39194123 |
173 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.37951863 |
174 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37473035 |
175 | regulation of translational fidelity (GO:0006450) | 2.36929729 |
176 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.36419811 |
177 | focal adhesion assembly (GO:0048041) | 2.35902914 |
178 | cell-substrate adherens junction assembly (GO:0007045) | 2.35902914 |
179 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.35814702 |
180 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.35814702 |
181 | cellular response to unfolded protein (GO:0034620) | 2.35055375 |
182 | IMP biosynthetic process (GO:0006188) | 2.34658032 |
183 | adherens junction assembly (GO:0034333) | 2.33516409 |
184 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.32207241 |
185 | protein insertion into membrane (GO:0051205) | 2.30502407 |
186 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.29806266 |
187 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.29620640 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.21317916 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.63381811 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.46172388 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.11228909 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.35016441 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.66676083 |
7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.48807635 |
8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.48380418 |
9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.38992238 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.33451940 |
11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.33006629 |
12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24927251 |
13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.20894406 |
14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.17660467 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 2.14918766 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.13451108 |
17 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.13030121 |
18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09887214 |
19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07685938 |
20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02492541 |
21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.91454488 |
22 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.91013205 |
23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90060709 |
24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89569080 |
25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.87227084 |
26 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.85948622 |
27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85921615 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85512455 |
29 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.83848635 |
30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83156945 |
31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.82196546 |
32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.81254019 |
33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71904697 |
34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70843121 |
35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70823468 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70217033 |
37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66923712 |
38 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.66424886 |
39 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63088320 |
40 | MAF_26560356_Chip-Seq_TH1_Human | 1.60552531 |
41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59820941 |
42 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.59713913 |
43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58828630 |
44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.58030490 |
45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52947914 |
46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.52130332 |
47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52078265 |
48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.48102508 |
49 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46631907 |
50 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.46075011 |
51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45581366 |
52 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45416995 |
53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43919713 |
54 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43122831 |
55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41566965 |
56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.41343100 |
57 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.36461195 |
58 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36438526 |
59 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.34953638 |
60 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.34364347 |
61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.33558166 |
62 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.33387783 |
63 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32543928 |
64 | P68_20966046_ChIP-Seq_HELA_Human | 1.32376750 |
65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.31416575 |
66 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.31292293 |
67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31099832 |
68 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30908888 |
69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27810533 |
70 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25794365 |
71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25665685 |
72 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25292755 |
73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25156219 |
74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24960687 |
75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24934533 |
76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24858952 |
77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24850277 |
78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24694959 |
79 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23637836 |
80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23007148 |
81 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.22421599 |
82 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22092398 |
83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22051544 |
84 | MAF_26560356_Chip-Seq_TH2_Human | 1.21654376 |
85 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21457982 |
86 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20394687 |
87 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20112101 |
88 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.18389555 |
89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18001746 |
90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17617466 |
91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16547569 |
92 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16189824 |
93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14988805 |
94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14660564 |
95 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.14076550 |
96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13759356 |
97 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13052047 |
98 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12850544 |
99 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12633276 |
100 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12091421 |
101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11594356 |
102 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.11507362 |
103 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11272458 |
104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11199034 |
105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09915193 |
106 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09526130 |
107 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09384839 |
108 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.08918937 |
109 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08390895 |
110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08338260 |
111 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07857196 |
112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07447514 |
113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07363765 |
114 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07354289 |
115 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07145341 |
116 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06877775 |
117 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06702859 |
118 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06207669 |
119 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.06039101 |
120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05535214 |
121 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05521935 |
122 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05176598 |
123 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04616953 |
124 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04508944 |
125 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.04370917 |
126 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03886144 |
127 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.03670056 |
128 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.03622986 |
129 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02501631 |
130 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02320409 |
131 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01978277 |
132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01932629 |
133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01932629 |
134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01472684 |
135 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.01079149 |
136 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00458273 |
137 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99897002 |
138 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99558550 |
139 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97690130 |
140 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97583592 |
141 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97446734 |
142 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95045053 |
143 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95024265 |
144 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94464555 |
145 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94277589 |
146 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94177495 |
147 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93704633 |
148 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.92574098 |
149 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92441751 |
150 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92033419 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.91573586 |
2 | MP0005360_urolithiasis | 4.26173726 |
3 | MP0005365_abnormal_bile_salt | 3.82688386 |
4 | MP0009840_abnormal_foam_cell | 3.68496971 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.68049632 |
6 | MP0005083_abnormal_biliary_tract | 3.01398833 |
7 | MP0004233_abnormal_muscle_weight | 2.63299382 |
8 | MP0010329_abnormal_lipoprotein_level | 2.56684311 |
9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.51449018 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.37886606 |
11 | MP0003252_abnormal_bile_duct | 2.31638436 |
12 | MP0002837_dystrophic_cardiac_calcinosis | 2.23441098 |
13 | MP0008260_abnormal_autophagy | 2.20731157 |
14 | MP0001666_abnormal_nutrient_absorption | 2.13298671 |
15 | MP0003705_abnormal_hypodermis_morpholog | 2.09997765 |
16 | MP0004130_abnormal_muscle_cell | 2.07486173 |
17 | MP0004510_myositis | 2.04367954 |
18 | MP0009278_abnormal_bone_marrow | 2.04036212 |
19 | MP0003806_abnormal_nucleotide_metabolis | 1.92768989 |
20 | MP0004858_abnormal_nervous_system | 1.91119689 |
21 | MP0005332_abnormal_amino_acid | 1.89950371 |
22 | MP0000609_abnormal_liver_physiology | 1.88798338 |
23 | MP0008438_abnormal_cutaneous_collagen | 1.87942555 |
24 | MP0002138_abnormal_hepatobiliary_system | 1.84163449 |
25 | MP0002118_abnormal_lipid_homeostasis | 1.83189368 |
26 | MP0000685_abnormal_immune_system | 1.81913073 |
27 | MP0003195_calcinosis | 1.78714031 |
28 | MP0003300_gastrointestinal_ulcer | 1.77470554 |
29 | MP0000750_abnormal_muscle_regeneration | 1.75404874 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.66356307 |
31 | MP0003656_abnormal_erythrocyte_physiolo | 1.65741004 |
32 | MP0001849_ear_inflammation | 1.63723311 |
33 | MP0003646_muscle_fatigue | 1.56974501 |
34 | MP0002332_abnormal_exercise_endurance | 1.56511455 |
35 | MP0000751_myopathy | 1.55795005 |
36 | MP0002909_abnormal_adrenal_gland | 1.53550143 |
37 | MP0003453_abnormal_keratinocyte_physiol | 1.48003521 |
38 | MP0000604_amyloidosis | 1.47231870 |
39 | MP0003303_peritoneal_inflammation | 1.46486323 |
40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44249004 |
41 | MP0005058_abnormal_lysosome_morphology | 1.42590897 |
42 | MP0006036_abnormal_mitochondrial_physio | 1.41851281 |
43 | MP0003329_amyloid_beta_deposits | 1.40274668 |
44 | MP0005397_hematopoietic_system_phenotyp | 1.39269514 |
45 | MP0001545_abnormal_hematopoietic_system | 1.39269514 |
46 | MP0005165_increased_susceptibility_to | 1.34928669 |
47 | MP0005666_abnormal_adipose_tissue | 1.34807728 |
48 | MP0003436_decreased_susceptibility_to | 1.34618606 |
49 | MP0005330_cardiomyopathy | 1.33646071 |
50 | MP0009333_abnormal_splenocyte_physiolog | 1.33267139 |
51 | MP0004185_abnormal_adipocyte_glucose | 1.32370540 |
52 | MP0009643_abnormal_urine_homeostasis | 1.31865670 |
53 | MP0000733_abnormal_muscle_development | 1.30759602 |
54 | MP0000747_muscle_weakness | 1.29552600 |
55 | MP0005464_abnormal_platelet_physiology | 1.29293251 |
56 | MP0000858_altered_metastatic_potential | 1.28832900 |
57 | MP0001661_extended_life_span | 1.24126440 |
58 | MP0002078_abnormal_glucose_homeostasis | 1.23654854 |
59 | MP0003111_abnormal_nucleus_morphology | 1.22147032 |
60 | MP0000013_abnormal_adipose_tissue | 1.22056797 |
61 | MP0003186_abnormal_redox_activity | 1.20935636 |
62 | MP0005501_abnormal_skin_physiology | 1.20556366 |
63 | MP0004145_abnormal_muscle_electrophysio | 1.17794963 |
64 | MP0008469_abnormal_protein_level | 1.17401399 |
65 | MP0008961_abnormal_basal_metabolism | 1.17216894 |
66 | MP0003693_abnormal_embryo_hatching | 1.14813453 |
67 | MP0002796_impaired_skin_barrier | 1.13508683 |
68 | MP0002148_abnormal_hypersensitivity_rea | 1.13240616 |
69 | MP0005375_adipose_tissue_phenotype | 1.13225904 |
70 | MP0004087_abnormal_muscle_fiber | 1.13183400 |
71 | MP0000598_abnormal_liver_morphology | 1.13108803 |
72 | MP0000749_muscle_degeneration | 1.11094173 |
73 | MP0005076_abnormal_cell_differentiation | 1.11037150 |
74 | MP0002269_muscular_atrophy | 1.09984995 |
75 | MP0002971_abnormal_brown_adipose | 1.09378431 |
76 | MP0002060_abnormal_skin_morphology | 1.08733311 |
77 | MP0005670_abnormal_white_adipose | 1.07926047 |
78 | MP0004036_abnormal_muscle_relaxation | 1.07823239 |
79 | MP0009785_altered_susceptibility_to | 1.07382454 |
80 | MP0004947_skin_inflammation | 1.07310578 |
81 | MP0005257_abnormal_intraocular_pressure | 1.06690227 |
82 | MP0003279_aneurysm | 1.04648228 |
83 | MP0001730_embryonic_growth_arrest | 1.01408308 |
84 | MP0003075_altered_response_to | 1.00651346 |
85 | MP0001790_abnormal_immune_system | 0.99297144 |
86 | MP0005387_immune_system_phenotype | 0.99297144 |
87 | MP0005025_abnormal_response_to | 0.98511584 |
88 | MP0005334_abnormal_fat_pad | 0.97280233 |
89 | MP0005636_abnormal_mineral_homeostasis | 0.97219341 |
90 | MP0005535_abnormal_body_temperature | 0.96219873 |
91 | MP0000003_abnormal_adipose_tissue | 0.95714110 |
92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95080820 |
93 | MP0003868_abnormal_feces_composition | 0.93973032 |
94 | MP0009642_abnormal_blood_homeostasis | 0.93158394 |
95 | MP0001835_abnormal_antigen_presentation | 0.92961510 |
96 | MP0005166_decreased_susceptibility_to | 0.92303876 |
97 | MP0001853_heart_inflammation | 0.91939927 |
98 | MP0003566_abnormal_cell_adhesion | 0.90738283 |
99 | MP0003724_increased_susceptibility_to | 0.90680995 |
100 | MP0009763_increased_sensitivity_to | 0.89755269 |
101 | MP0004272_abnormal_basement_membrane | 0.86157783 |
102 | MP0000678_abnormal_parathyroid_gland | 0.85657182 |
103 | MP0003172_abnormal_lysosome_physiology | 0.85525697 |
104 | MP0005369_muscle_phenotype | 0.85073869 |
105 | MP0001765_abnormal_ion_homeostasis | 0.84588314 |
106 | MP0005023_abnormal_wound_healing | 0.83248205 |
107 | MP0003045_fibrosis | 0.83108073 |
108 | MP0000759_abnormal_skeletal_muscle | 0.83082752 |
109 | MP0009780_abnormal_chondrocyte_physiolo | 0.83050677 |
110 | MP0001727_abnormal_embryo_implantation | 0.82586104 |
111 | MP0002693_abnormal_pancreas_physiology | 0.82227950 |
112 | MP0002970_abnormal_white_adipose | 0.82043975 |
113 | MP0000681_abnormal_thyroid_gland | 0.81786780 |
114 | MP0010234_abnormal_vibrissa_follicle | 0.81723019 |
115 | MP0001845_abnormal_inflammatory_respons | 0.80729216 |
116 | MP0002877_abnormal_melanocyte_morpholog | 0.80345320 |
117 | MP0009672_abnormal_birth_weight | 0.80235239 |
118 | MP0002998_abnormal_bone_remodeling | 0.79847906 |
119 | MP0001533_abnormal_skeleton_physiology | 0.79665035 |
120 | MP0001944_abnormal_pancreas_morphology | 0.79513838 |
121 | MP0005451_abnormal_body_composition | 0.79409786 |
122 | MP0003091_abnormal_cell_migration | 0.78347154 |
123 | MP0010352_gastrointestinal_tract_polyps | 0.77036174 |
124 | MP0010630_abnormal_cardiac_muscle | 0.76597836 |
125 | MP0005621_abnormal_cell_physiology | 0.76300943 |
126 | MP0000313_abnormal_cell_death | 0.75699931 |
127 | MP0002106_abnormal_muscle_physiology | 0.74649075 |
128 | MP0005220_abnormal_exocrine_pancreas | 0.74354747 |
129 | MP0000358_abnormal_cell_content/ | 0.74074406 |
130 | MP0004084_abnormal_cardiac_muscle | 0.72978454 |
131 | MP0002166_altered_tumor_susceptibility | 0.72511490 |
132 | MP0006082_CNS_inflammation | 0.72350221 |
133 | MP0000490_abnormal_crypts_of | 0.72205116 |
134 | MP0008775_abnormal_heart_ventricle | 0.72199963 |
135 | MP0005385_cardiovascular_system_phenoty | 0.72186150 |
136 | MP0001544_abnormal_cardiovascular_syste | 0.72186150 |
137 | MP0001348_abnormal_lacrimal_gland | 0.71898998 |
138 | MP0001800_abnormal_humoral_immune | 0.71737981 |
139 | MP0004808_abnormal_hematopoietic_stem | 0.71422960 |
140 | MP0009115_abnormal_fat_cell | 0.71162070 |
141 | MP0000343_altered_response_to | 0.70402763 |
142 | MP0002254_reproductive_system_inflammat | 0.70284923 |
143 | MP0003448_altered_tumor_morphology | 0.70163232 |
144 | MP0005448_abnormal_energy_balance | 0.69917016 |
145 | MP0010030_abnormal_orbit_morphology | 0.69784849 |
146 | MP0002080_prenatal_lethality | 0.69369371 |
147 | MP0001243_abnormal_dermal_layer | 0.68519523 |
148 | MP0008007_abnormal_cellular_replicative | 0.68113691 |
149 | MP0010155_abnormal_intestine_physiology | 0.67577619 |
150 | * MP0009931_abnormal_skin_appearance | 0.67540506 |
151 | MP0003828_pulmonary_edema | 0.67195497 |
152 | MP0003183_abnormal_peptide_metabolism | 0.67105836 |
153 | MP0002419_abnormal_innate_immunity | 0.66810609 |
154 | MP0001756_abnormal_urination | 0.66241640 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 4.49591119 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.43011163 |
3 | Muscle fiber inclusion bodies (HP:0100299) | 4.28782226 |
4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.25248238 |
5 | Nemaline bodies (HP:0003798) | 4.24722922 |
6 | Xanthomatosis (HP:0000991) | 4.17363898 |
7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.07246313 |
8 | Ketosis (HP:0001946) | 3.83358793 |
9 | Myopathic facies (HP:0002058) | 3.80949552 |
10 | Type 1 muscle fiber predominance (HP:0003803) | 3.78686041 |
11 | Increased connective tissue (HP:0009025) | 3.65475707 |
12 | Distal lower limb muscle weakness (HP:0009053) | 3.58177944 |
13 | Hypoglycemic coma (HP:0001325) | 3.57564548 |
14 | Hyperlipoproteinemia (HP:0010980) | 3.57353957 |
15 | Intrahepatic cholestasis (HP:0001406) | 3.50043725 |
16 | Ketoacidosis (HP:0001993) | 3.45124765 |
17 | Myoglobinuria (HP:0002913) | 3.34560976 |
18 | Distal lower limb amyotrophy (HP:0008944) | 3.33217948 |
19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.26376437 |
20 | Vertebral compression fractures (HP:0002953) | 3.25045731 |
21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.18184769 |
22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.18184769 |
23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.18184769 |
24 | Exercise-induced myalgia (HP:0003738) | 3.10176987 |
25 | Hypobetalipoproteinemia (HP:0003563) | 3.05316557 |
26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.00759333 |
27 | Abnormality of the common coagulation pathway (HP:0010990) | 2.96846110 |
28 | Hyperammonemia (HP:0001987) | 2.92828205 |
29 | Complement deficiency (HP:0004431) | 2.88325276 |
30 | Polycythemia (HP:0001901) | 2.87781397 |
31 | Asymmetric septal hypertrophy (HP:0001670) | 2.84085870 |
32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.83927626 |
33 | Prolonged partial thromboplastin time (HP:0003645) | 2.79949327 |
34 | Abnormality of the nasal mucosa (HP:0000433) | 2.72726457 |
35 | Increased variability in muscle fiber diameter (HP:0003557) | 2.72489453 |
36 | Abnormality of the intrinsic pathway (HP:0010989) | 2.70829800 |
37 | EMG: myopathic abnormalities (HP:0003458) | 2.69091386 |
38 | Late onset (HP:0003584) | 2.67513320 |
39 | Hyperacusis (HP:0010780) | 2.64926392 |
40 | Abnormality of the Achilles tendon (HP:0005109) | 2.64289095 |
41 | Spinal rigidity (HP:0003306) | 2.63221750 |
42 | Cholecystitis (HP:0001082) | 2.62288606 |
43 | Abnormal gallbladder physiology (HP:0012438) | 2.62288606 |
44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56562605 |
45 | Ulnar deviation of the wrist (HP:0003049) | 2.53839354 |
46 | Cholelithiasis (HP:0001081) | 2.53499902 |
47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.53324517 |
48 | Hypolipoproteinemia (HP:0010981) | 2.52881507 |
49 | Neck muscle weakness (HP:0000467) | 2.50694836 |
50 | Nasal polyposis (HP:0100582) | 2.50601449 |
51 | Back pain (HP:0003418) | 2.50290700 |
52 | Premature rupture of membranes (HP:0001788) | 2.48505680 |
53 | Exercise-induced muscle cramps (HP:0003710) | 2.45665157 |
54 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.44518182 |
55 | Hypoalphalipoproteinemia (HP:0003233) | 2.44165785 |
56 | Muscle fiber splitting (HP:0003555) | 2.43352918 |
57 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.41575604 |
58 | Abnormal gallbladder morphology (HP:0012437) | 2.41555199 |
59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.40655540 |
60 | Abnormality of glycine metabolism (HP:0010895) | 2.40655540 |
61 | Hyperbilirubinemia (HP:0002904) | 2.38992674 |
62 | Achilles tendon contracture (HP:0001771) | 2.38370455 |
63 | Reticulocytosis (HP:0001923) | 2.37652017 |
64 | Abnormality of complement system (HP:0005339) | 2.35739305 |
65 | Sudden death (HP:0001699) | 2.35462429 |
66 | Joint hemorrhage (HP:0005261) | 2.35364690 |
67 | Bulbar palsy (HP:0001283) | 2.34024836 |
68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.33441555 |
69 | Rhabdomyolysis (HP:0003201) | 2.32809609 |
70 | Increased cerebral lipofuscin (HP:0011813) | 2.32540354 |
71 | Hyperglycinemia (HP:0002154) | 2.32389213 |
72 | Hypercholesterolemia (HP:0003124) | 2.31924142 |
73 | Axonal loss (HP:0003447) | 2.29806640 |
74 | Insomnia (HP:0100785) | 2.27380969 |
75 | Round ear (HP:0100830) | 2.26903735 |
76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26250889 |
77 | Dicarboxylic aciduria (HP:0003215) | 2.26250889 |
78 | Lower limb amyotrophy (HP:0007210) | 2.26227487 |
79 | Hyperglycinuria (HP:0003108) | 2.25535359 |
80 | Diaphragmatic weakness (HP:0009113) | 2.23824660 |
81 | Hypertensive crisis (HP:0100735) | 2.17963909 |
82 | Trismus (HP:0000211) | 2.17721534 |
83 | Hyporeflexia of lower limbs (HP:0002600) | 2.17544255 |
84 | Fatigue (HP:0012378) | 2.17017122 |
85 | Generalized amyotrophy (HP:0003700) | 2.13479465 |
86 | Skin nodule (HP:0200036) | 2.13381617 |
87 | Protrusio acetabuli (HP:0003179) | 2.12903654 |
88 | Neonatal onset (HP:0003623) | 2.12557340 |
89 | Stridor (HP:0010307) | 2.12244177 |
90 | Gout (HP:0001997) | 2.11190361 |
91 | Increased serum ferritin (HP:0003281) | 2.10117280 |
92 | Delayed CNS myelination (HP:0002188) | 2.08930859 |
93 | Mitral stenosis (HP:0001718) | 2.08753688 |
94 | Nuclear cataract (HP:0100018) | 2.06694495 |
95 | Foot dorsiflexor weakness (HP:0009027) | 2.03566831 |
96 | Ragged-red muscle fibers (HP:0003200) | 2.01144026 |
97 | Interstitial pulmonary disease (HP:0006530) | 2.01100164 |
98 | Hypoglycemic seizures (HP:0002173) | 2.00142206 |
99 | Myocardial infarction (HP:0001658) | 1.99965905 |
100 | Right ventricular cardiomyopathy (HP:0011663) | 1.99892540 |
101 | Menorrhagia (HP:0000132) | 1.99603545 |
102 | Epidermoid cyst (HP:0200040) | 1.99384405 |
103 | Abnormality of iron homeostasis (HP:0011031) | 1.97746302 |
104 | Abnormality of glycolysis (HP:0004366) | 1.97344260 |
105 | Short nail (HP:0001799) | 1.95626553 |
106 | Chronic otitis media (HP:0000389) | 1.95506990 |
107 | Amyloidosis (HP:0011034) | 1.94013930 |
108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93247383 |
109 | Rough bone trabeculation (HP:0100670) | 1.92317703 |
110 | Fat malabsorption (HP:0002630) | 1.92160820 |
111 | Generalized aminoaciduria (HP:0002909) | 1.90981336 |
112 | Abnormality of proline metabolism (HP:0010907) | 1.90780537 |
113 | Hydroxyprolinuria (HP:0003080) | 1.90780537 |
114 | Abnormality of purine metabolism (HP:0004352) | 1.90702620 |
115 | Limb-girdle muscle atrophy (HP:0003797) | 1.90683182 |
116 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89917249 |
117 | Metabolic acidosis (HP:0001942) | 1.89457751 |
118 | Abnormality of the umbilical cord (HP:0010881) | 1.89375494 |
119 | Muscle stiffness (HP:0003552) | 1.88415528 |
120 | Ventricular tachycardia (HP:0004756) | 1.87135985 |
121 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86938669 |
122 | Distal arthrogryposis (HP:0005684) | 1.86391785 |
123 | Systemic lupus erythematosus (HP:0002725) | 1.86086760 |
124 | Loss of speech (HP:0002371) | 1.85677647 |
125 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.83532196 |
126 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83521161 |
127 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83521161 |
128 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83521161 |
129 | Progressive external ophthalmoplegia (HP:0000590) | 1.83392624 |
130 | Scapular winging (HP:0003691) | 1.82904963 |
131 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82807850 |
132 | Mucopolysacchariduria (HP:0008155) | 1.82807850 |
133 | Abnormality of the gallbladder (HP:0005264) | 1.82805309 |
134 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.82729094 |
135 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.82729094 |
136 | Upper limb amyotrophy (HP:0009129) | 1.80783032 |
137 | Distal upper limb amyotrophy (HP:0007149) | 1.80783032 |
138 | Impaired platelet aggregation (HP:0003540) | 1.80756087 |
139 | Abnormal platelet function (HP:0011869) | 1.80756087 |
140 | Multiple enchondromatosis (HP:0005701) | 1.80277989 |
141 | Abnormality of the foot musculature (HP:0001436) | 1.79843933 |
142 | Dysostosis multiplex (HP:0000943) | 1.78532682 |
143 | Gingival bleeding (HP:0000225) | 1.77307440 |
144 | Abnormal cartilage morphology (HP:0002763) | 1.76739195 |
145 | Progressive muscle weakness (HP:0003323) | 1.76609562 |
146 | Atrioventricular block (HP:0001678) | 1.76515721 |
147 | Upper motor neuron abnormality (HP:0002127) | 1.75311285 |
148 | Increased serum pyruvate (HP:0003542) | 1.74453658 |
149 | Microvesicular hepatic steatosis (HP:0001414) | 1.74200994 |
150 | Calcaneovalgus deformity (HP:0001848) | 1.73374914 |
151 | Difficulty running (HP:0009046) | 1.73346225 |
152 | Vacuolated lymphocytes (HP:0001922) | 1.73080084 |
153 | Epistaxis (HP:0000421) | 1.72908886 |
154 | Spontaneous hematomas (HP:0007420) | 1.71055299 |
155 | Protuberant abdomen (HP:0001538) | 1.71044313 |
156 | Athetosis (HP:0002305) | 1.70678349 |
157 | Microcytic anemia (HP:0001935) | 1.70675959 |
158 | Stroke (HP:0001297) | 1.70663044 |
159 | Conjunctival hamartoma (HP:0100780) | 1.69970680 |
160 | Rimmed vacuoles (HP:0003805) | 1.69736134 |
161 | Difficulty climbing stairs (HP:0003551) | 1.69487602 |
162 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.69327376 |
163 | Shoulder girdle muscle weakness (HP:0003547) | 1.67973345 |
164 | Slender build (HP:0001533) | 1.65620105 |
165 | Abnormality of the tricuspid valve (HP:0001702) | 1.65277048 |
166 | Fasciculations (HP:0002380) | 1.65018708 |
167 | Thoracic kyphosis (HP:0002942) | 1.63167733 |
168 | Prolonged neonatal jaundice (HP:0006579) | 1.63063803 |
169 | Polygenic inheritance (HP:0010982) | 1.62890446 |
170 | Hepatosplenomegaly (HP:0001433) | 1.61984592 |
171 | Abnormality of the thoracic spine (HP:0100711) | 1.61716376 |
172 | Natal tooth (HP:0000695) | 1.60501800 |
173 | Elbow flexion contracture (HP:0002987) | 1.59691413 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 5.22994408 |
2 | ERN1 | 4.14928542 |
3 | PKN2 | 4.05670392 |
4 | BCKDK | 3.31213149 |
5 | SMG1 | 3.22920406 |
6 | TESK1 | 2.66808761 |
7 | PRPF4B | 2.60698943 |
8 | FGFR4 | 2.50830713 |
9 | MAP4K1 | 2.13384850 |
10 | MAP3K10 | 2.12708239 |
11 | TTN | 2.11889317 |
12 | SIK1 | 2.11494612 |
13 | TYK2 | 2.08636039 |
14 | EEF2K | 2.07155867 |
15 | TAOK2 | 2.00729516 |
16 | FLT3 | 1.89524911 |
17 | VRK2 | 1.89508894 |
18 | EPHB1 | 1.85845396 |
19 | PTK6 | 1.77699781 |
20 | TBK1 | 1.67718439 |
21 | EPHA2 | 1.62912390 |
22 | LIMK1 | 1.57370862 |
23 | MAP3K3 | 1.47865748 |
24 | LRRK2 | 1.46765300 |
25 | JAK1 | 1.43075646 |
26 | KSR2 | 1.35993317 |
27 | JAK3 | 1.33205069 |
28 | TAOK3 | 1.32245351 |
29 | PAK4 | 1.28883322 |
30 | MAP3K7 | 1.28494498 |
31 | MAP3K13 | 1.21428821 |
32 | BUB1 | 1.18645031 |
33 | MAPK11 | 1.17758108 |
34 | RIPK1 | 1.17131829 |
35 | BLK | 1.16638924 |
36 | PHKG1 | 1.14814415 |
37 | PHKG2 | 1.14814415 |
38 | MAP3K1 | 1.14766862 |
39 | MAP3K11 | 1.14305368 |
40 | ZAP70 | 1.12842352 |
41 | RET | 1.12106996 |
42 | KIT | 1.11143038 |
43 | PDGFRA | 1.06959744 |
44 | LMTK2 | 1.06904537 |
45 | SCYL2 | 1.06050659 |
46 | JAK2 | 1.05007777 |
47 | PRKD3 | 1.01403656 |
48 | TAOK1 | 1.00784930 |
49 | CAMKK1 | 0.99317007 |
50 | INSRR | 0.97621695 |
51 | NTRK1 | 0.94966777 |
52 | ICK | 0.93758125 |
53 | PBK | 0.93140085 |
54 | MOS | 0.92262358 |
55 | HIPK2 | 0.91667301 |
56 | GRK6 | 0.91017872 |
57 | DAPK1 | 0.87588060 |
58 | IKBKE | 0.87200643 |
59 | BTK | 0.81122013 |
60 | MAP2K3 | 0.81004150 |
61 | DDR2 | 0.78504696 |
62 | PIM2 | 0.78039353 |
63 | RPS6KB2 | 0.77357001 |
64 | KDR | 0.76554890 |
65 | BRAF | 0.75398717 |
66 | EPHA3 | 0.75379849 |
67 | CAMK2G | 0.74621193 |
68 | ILK | 0.74203219 |
69 | BMX | 0.74141170 |
70 | TGFBR2 | 0.73811070 |
71 | CSK | 0.72704359 |
72 | PDK3 | 0.72245908 |
73 | PDK4 | 0.72245908 |
74 | MAP3K2 | 0.71440969 |
75 | AURKA | 0.71297711 |
76 | DAPK3 | 0.71015461 |
77 | DYRK1B | 0.70447351 |
78 | ARAF | 0.69833737 |
79 | PDPK1 | 0.69658391 |
80 | CDC42BPA | 0.69232172 |
81 | NEK1 | 0.69065548 |
82 | CCNB1 | 0.68687184 |
83 | FGFR3 | 0.67252166 |
84 | PDK1 | 0.66320525 |
85 | SYK | 0.66118164 |
86 | AKT2 | 0.65221893 |
87 | PRKD1 | 0.64608815 |
88 | NME2 | 0.63746834 |
89 | CSF1R | 0.63102936 |
90 | ALK | 0.62476862 |
91 | PTK2B | 0.61976061 |
92 | MST1R | 0.61858579 |
93 | EIF2AK1 | 0.61768083 |
94 | PRKCH | 0.61443971 |
95 | DAPK2 | 0.61078272 |
96 | MAP2K2 | 0.60925205 |
97 | CDK7 | 0.60214387 |
98 | FES | 0.59899417 |
99 | MAPK15 | 0.56948662 |
100 | CDK9 | 0.55345748 |
101 | CDK12 | 0.55219171 |
102 | SIK2 | 0.54912929 |
103 | MAP3K9 | 0.54423722 |
104 | TIE1 | 0.51561936 |
105 | HCK | 0.51093212 |
106 | MAPK12 | 0.51008564 |
107 | IRAK2 | 0.50885309 |
108 | PAK1 | 0.49361946 |
109 | LATS2 | 0.49164135 |
110 | PTK2 | 0.48459452 |
111 | CDK4 | 0.47725154 |
112 | CAMKK2 | 0.46282160 |
113 | RPS6KL1 | 0.46193658 |
114 | RPS6KC1 | 0.46193658 |
115 | RAF1 | 0.45673604 |
116 | OBSCN | 0.45501196 |
117 | RPS6KA2 | 0.45344601 |
118 | DMPK | 0.43786702 |
119 | STK16 | 0.43046535 |
120 | PRKD2 | 0.42795134 |
121 | TLK1 | 0.42773370 |
122 | MAPK4 | 0.42318419 |
123 | PIK3CG | 0.42014481 |
124 | MATK | 0.41695932 |
125 | NEK9 | 0.41640778 |
126 | PINK1 | 0.41493495 |
127 | TESK2 | 0.40429889 |
128 | MAP3K8 | 0.40335394 |
129 | PAK6 | 0.39816703 |
130 | PAK2 | 0.39204725 |
131 | MAPKAPK2 | 0.38975151 |
132 | CAMK1D | 0.38441337 |
133 | MAP3K14 | 0.37877377 |
134 | RPS6KA4 | 0.37681806 |
135 | STK10 | 0.36893614 |
136 | MTOR | 0.36391878 |
137 | MAPKAPK3 | 0.35605629 |
138 | CAMK1G | 0.35376931 |
139 | ABL2 | 0.34431485 |
140 | ERBB4 | 0.34015784 |
141 | CDK8 | 0.33678126 |
142 | CDK11A | 0.33598057 |
143 | IRAK3 | 0.32137588 |
144 | PRKG2 | 0.31784683 |
145 | PRKAA2 | 0.31769817 |
146 | CDK15 | 0.30944053 |
147 | MAP3K5 | 0.29849065 |
148 | CDK14 | 0.29783561 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.90442786 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.42919297 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.37477829 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.08115898 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.79126254 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75429415 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42608556 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.32548800 |
9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.26857349 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.26142576 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24086541 |
12 | DNA replication_Homo sapiens_hsa03030 | 2.12144284 |
13 | Base excision repair_Homo sapiens_hsa03410 | 2.00239482 |
14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.99169097 |
15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.96624225 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95894869 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93014714 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84848015 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83028091 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77953757 |
21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69267111 |
22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59693439 |
23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.58547620 |
24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56424815 |
25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50402525 |
26 | Peroxisome_Homo sapiens_hsa04146 | 1.48345457 |
27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46990814 |
28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45743745 |
29 | Bile secretion_Homo sapiens_hsa04976 | 1.42914745 |
30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.40842222 |
31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37876400 |
32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.35850352 |
33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34642792 |
34 | ABC transporters_Homo sapiens_hsa02010 | 1.34046014 |
35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31768681 |
36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30954781 |
37 | Insulin resistance_Homo sapiens_hsa04931 | 1.27666286 |
38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.27127300 |
39 | Proteasome_Homo sapiens_hsa03050 | 1.24193466 |
40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23688983 |
41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21299996 |
42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20252572 |
43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.17693820 |
44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16149013 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12082828 |
46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11462106 |
47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10625574 |
48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10075287 |
49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.09218421 |
50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08458298 |
51 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06144941 |
52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06078906 |
53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03049660 |
54 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02237895 |
55 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02152219 |
56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01900284 |
57 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01430511 |
58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00595897 |
59 | Salmonella infection_Homo sapiens_hsa05132 | 0.94311662 |
60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92518430 |
61 | Shigellosis_Homo sapiens_hsa05131 | 0.92434108 |
62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88276237 |
63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87309114 |
64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86238390 |
65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83508258 |
66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80246700 |
67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77507919 |
68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76610863 |
69 | Apoptosis_Homo sapiens_hsa04210 | 0.76223726 |
70 | Lysine degradation_Homo sapiens_hsa00310 | 0.74875549 |
71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74569615 |
72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73628618 |
73 | Pertussis_Homo sapiens_hsa05133 | 0.73194425 |
74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72372695 |
75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72047827 |
76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71989831 |
77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68629127 |
78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68189068 |
79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67620104 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67600199 |
81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67467165 |
82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67171555 |
83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66744200 |
84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66512190 |
85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63875562 |
86 | Prion diseases_Homo sapiens_hsa05020 | 0.61764686 |
87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57408484 |
88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56505666 |
89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55684502 |
90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54698898 |
91 | Hepatitis C_Homo sapiens_hsa05160 | 0.54456859 |
92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54381193 |
93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53687228 |
94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53509031 |
95 | Legionellosis_Homo sapiens_hsa05134 | 0.52093928 |
96 | Spliceosome_Homo sapiens_hsa03040 | 0.51157295 |
97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50651251 |
98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50491384 |
99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47740658 |
100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47397743 |
101 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.46373951 |
102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46120040 |
103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45613919 |
104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45366017 |
105 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45288167 |
106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45170542 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.43921634 |
108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43530153 |
109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42818419 |
110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41571750 |
111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41436366 |
112 | Influenza A_Homo sapiens_hsa05164 | 0.40813699 |
113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39437800 |
114 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39379492 |
115 | Amoebiasis_Homo sapiens_hsa05146 | 0.39349951 |
116 | Hepatitis B_Homo sapiens_hsa05161 | 0.39228408 |
117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39055814 |
118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38206520 |
119 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.38101029 |
120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37975117 |
121 | Lysosome_Homo sapiens_hsa04142 | 0.37310947 |
122 | Bladder cancer_Homo sapiens_hsa05219 | 0.36842532 |
123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35030279 |
124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.34852294 |
125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33989616 |
126 | Mismatch repair_Homo sapiens_hsa03430 | 0.33296895 |
127 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32949046 |
128 | Platelet activation_Homo sapiens_hsa04611 | 0.32632775 |
129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31121708 |
130 | Leishmaniasis_Homo sapiens_hsa05140 | 0.30268607 |
131 | Focal adhesion_Homo sapiens_hsa04510 | 0.30152391 |
132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.29204403 |
133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28454106 |
134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28225313 |
135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27485324 |
136 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27460976 |
137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26971658 |
138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26369900 |
139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25328072 |
140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24083335 |
141 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24077015 |
142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23285792 |
143 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21408756 |
144 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20522858 |
145 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.18575585 |
146 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.18498639 |
147 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18045831 |
148 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.17388406 |
149 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16893419 |
150 | Glioma_Homo sapiens_hsa05214 | 0.16366818 |